On January 15, 2026, Professor Paul Hofman (Director of IHU RespirERA) participated in the scientific session of the COALA (Cure Oncogene-Addicted Lung Adenocarcinoma) network. This landmark event brought together experts to pursue a shared objective: transforming the care of poor-prognosis lung cancers.
COALA: A Network of Excellence Serving Patients
The COALA program, funded by the French National Cancer Institute (INCa), aims to structure French research to better understand and treat aggressive forms of lung cancer. By fostering collaboration between researchers and physicians, this network accelerates therapeutic innovation to offer new hope to patients.
Exposome: Understanding the Impact of Our Environment
As a guest speaker at this session, Professor Paul Hofman addressed a crucial theme: "Exposome and Environment".
But what exactly is the exposome? It refers to the totality of exposures—such as atmospheric pollutants, lifestyle choices, and occupational factors, that individuals encounter throughout their lives. For IHU RespirERA, understanding how these factors influence pulmonary health and promote the onset of cancer is a top priority.
A Multidisciplinary Vision for the Future
Beyond his presentation, Professor Hofman participated in a strategic round table discussion regarding innovative clinical trials. This participation underscores the driving role of IHU RespirERA in building a more preventive and personalized respiratory medicine.
